phosphotyrosine has been researched along with cholecystokinin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bragado, MJ; Ernst, SA; Groblewski, GE; Ross, SE; Schäfer, C; Williams, JA | 1 |
| Ohlsson, B; Rehfeld, JF; Sundler, F | 1 |
| Bragado, MJ; García-Marin, LJ; Jensen, RT; Pace, A; Tapia, JA | 1 |
| Andreolotti, AG; Bragado, MJ; Garcia-Marin, LJ; Jensen, RT; Tapia, JA | 1 |
| Berna, MJ; Hoffmann, KM; Jensen, RT; Mantey, SA; Pace, A; Tapia, JA; Thill, M | 1 |
5 other study(ies) available for phosphotyrosine and cholecystokinin
| Article | Year |
|---|---|
A role for the p38 mitogen-activated protein kinase/Hsp 27 pathway in cholecystokinin-induced changes in the actin cytoskeleton in rat pancreatic acini.
Topics: Actins; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell-Free System; Cholecystokinin; Cytoskeleton; Enzyme Activation; Enzyme Inhibitors; Hypertonic Solutions; Imidazoles; Intracellular Signaling Peptides and Proteins; Kinetics; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pancreas; Phosphorylation; Phosphotyrosine; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Signal Transduction; Sincalide; Sorbitol | 1998 |
Cholecystokinin does not affect the pancreatic contents of epidermal growth factor or its receptor.
Topics: Animals; Body Weight; Bromodeoxyuridine; Cholecystokinin; Epidermal Growth Factor; ErbB Receptors; Immunohistochemistry; In Situ Hybridization; Male; Organ Size; Pancreas; Phosphotyrosine; Rats; Rats, Sprague-Dawley | 2000 |
Phosphospecific site tyrosine phosphorylation of p125FAK and proline-rich kinase 2 is differentially regulated by cholecystokinin receptor type A activation in pancreatic acini.
Topics: Animals; Binding Sites; Calcium; Cholecystokinin; Diglycerides; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Focal Adhesion Kinase 1; Focal Adhesion Kinase 2; Focal Adhesion Protein-Tyrosine Kinases; Hydrolysis; Indoles; Inositol Phosphates; Kinetics; Male; Maleimides; Pancreas; Phosphatidylinositol 4,5-Diphosphate; Phosphorylation; Phosphotyrosine; Protein Kinase C; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Sincalide; Tetradecanoylphorbol Acetate; Thapsigargin; Type C Phospholipases | 2003 |
Cholecystokinin rapidly stimulates CrkII function in vivo in rat pancreatic acini. Formation of CrkII-protein complexes.
Topics: Animals; Calcium; Cholecystokinin; Crk-Associated Substrate Protein; Cytoskeletal Proteins; Enzyme Activation; In Vitro Techniques; Macromolecular Substances; Male; Pancreas; Paxillin; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein Binding; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-crk; Rats; Rats, Wistar; Retinoblastoma-Like Protein p130; Sincalide; Time Factors | 2003 |
CCK causes PKD1 activation in pancreatic acini by signaling through PKC-delta and PKC-independent pathways.
Topics: Animals; Bombesin; Calcium; Carbachol; Cholecystokinin; Dose-Response Relationship, Drug; Enzyme Activation; Growth Substances; Isoenzymes; Male; Mitogen-Activated Protein Kinases; Pancreas, Exocrine; Phosphoserine; Phosphotyrosine; Protein Kinase C; Protein Kinase C-delta; Protein Kinase Inhibitors; Protein Kinases; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Signal Transduction; Tetradecanoylphorbol Acetate; Time Factors; Type C Phospholipases | 2007 |